ArticleSe pu = Chinese journal of chromatography2026
[Establishment and application of a knowledge-directed pseudo-targeted analytical method for diabetic retinopathy].
Article in Se pu = Chinese journal of chromatography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is a common blinding eye disease caused by diabetes mellitus and is the leading cause of acquired vision loss in adults worldwide. DR is asymptomatic in its early stages, and patients often miss the optimal treatment window by the time they seek medical attention due to vision impairment. Traditional methods used for DR diagnosis have inherent limitations and are not conducive to large-scale rapid screening. Biomarkers can reflect the stage of the disease owing to their specificity and sensitivity, which is crucial for the early diagnosis of DR. In the present study, 142 potential literature-based biomarkers associated with DR were included in a knowledge-directed strategy. And metabolites with different physicochemical properties were chromatographically separated using a 100-mm Discovery HS F5 column. A pseudo-targeted metabolomics method based on ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) that simultaneously scans positive and negative ions was established to improve analysis coverage and throughput. The method was validated using eight representative isotope-labeled internal standards as analytical targets. All isotope-labeled internal standards exhibited satisfactory linearities in both positive- and negative-ionization modes, with linear dynamic ranges spanning over three orders of magnitude and correlation coefficients (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.